Mega TP, Silva RM da. Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system. Rev. saúde pública [Internet]. 2023 Jul. 19 [cited 2024 May 16];57(1):41. Available from: https://www.revistas.usp.br/rsp/article/view/214471